JUBILANT PHARMOVA is trading at 619.80 as of the 24th of September 2021, a 2.14 percent increase since the beginning of the trading day. The stock's open price was 606.8. Equity ratings for JUBILANT PHARMOVA LIMITED are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 5th of October 2019 and ending today, the 24th of September 2021. Click here to learn more.


JUBILANT PHARMOVA is not yet fully synchronised with the market data
JUBILANT PHARMOVA generates negative expected return over the last 90 days
JUBILANT PHARMOVA has high historical volatility and very poor performance
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of JUBILANT PHARMOVA's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedOvervalued
JUBILANT PHARMOVA LIMITED (JUBLPHARMA) is traded on Bombay Stock Exchange in India .
Check JUBILANT PHARMOVA Probability Of Bankruptcy

JUBILANT Stock Price Odds Analysis

What are JUBILANT PHARMOVA's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of JUBILANT PHARMOVA jumping above the current price in 90 days from now is about 78.04%. The JUBILANT PHARMOVA LIMITED probability density function shows the probability of JUBILANT PHARMOVA stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon JUBILANT PHARMOVA has a beta of 0.0179. This indicates as returns on the market go up, JUBILANT PHARMOVA average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding JUBILANT PHARMOVA LIMITED will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. JUBILANT PHARMOVA is significantly underperforming DOW.
 Odds Down 619.8HorizonTargetOdds Up 619.8 
21.83%90 days
Based on a normal probability distribution, the odds of JUBILANT PHARMOVA to move above the current price in 90 days from now is about 78.04 (This JUBILANT PHARMOVA LIMITED probability density function shows the probability of JUBILANT Stock to fall within a particular range of prices over 90 days) .


Investors will always prefer to have the highest possible return on investment while minimizing volatility. JUBILANT PHARMOVA market risk premium is the additional return an investor will receive from holding JUBILANT PHARMOVA long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in JUBILANT PHARMOVA. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although JUBILANT PHARMOVA's alpha and beta are two of the key measurements used to evaluate JUBILANT PHARMOVA's performance over the market, the standard measures of volatility play an important role as well.

JUBILANT Stock Against Markets

Picking the right benchmark for JUBILANT PHARMOVA stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in JUBILANT PHARMOVA stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for JUBILANT PHARMOVA is critical whether you are bullish or bearish towards JUBILANT PHARMOVA LIMITED at a given time.

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with JUBILANT PHARMOVA stock to make a market-neutral strategy. Peer analysis of JUBILANT PHARMOVA could also be used in its relative valuation, which is a method of valuing JUBILANT PHARMOVA by comparing valuation metrics with similar companies.
Please see Risk vs Return Analysis. Note that the JUBILANT PHARMOVA information on this page should be used as a complementary analysis to other JUBILANT PHARMOVA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Tools for JUBILANT Stock

When running JUBILANT PHARMOVA price analysis, check to measure JUBILANT PHARMOVA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy JUBILANT PHARMOVA is operating at the current time. Most of JUBILANT PHARMOVA's value examination focuses on studying past and present price action to predict the probability of JUBILANT PHARMOVA's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move JUBILANT PHARMOVA's price. Additionally, you may evaluate how the addition of JUBILANT PHARMOVA to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Insider Screener
Find insiders across different sectors to evaluate their impact on performance